[PDF] Top 20 Periodontitis como factor de riesgo de enfermedades cardiovasculares
Has 10000 "Periodontitis como factor de riesgo de enfermedades cardiovasculares" found on our website. Below are the top 20 most common "Periodontitis como factor de riesgo de enfermedades cardiovasculares".
Grid laser with modified pro re nata injection of bevacizumab and ranibizumab in macular edema due to branch retinal vein occlusion: MARVEL report no 2
... that macular laser photocoagulation may reduce the injection burden in eyes with BRVO, but its exact role has not been well ...the MARVEL trial, rescue laser was per- formed during the ... See full document
6
Retinal Functional Changes Measured by Microperimetry after Intravitreal Ranibizumab Injection and Sulfotanshinone Sodium Injection for Macular Edema Secondary to Retinal Vein Occlusion
... Retinal vein occlusion (RVO) is estimated to be the second most common cause of retinal vascular disease ...[1]. Macular edema (ME) is a frequent cause of visual acuity loss ... See full document
108
The Results of Intravitreal Bevacizumab Injections and Laser Photocoagulation for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion
... compared bevacizumab alone or combined with macular laser photocoagulation for the treatment of macular edema secondary to ...of bevacizumab and ranibizumab treatments of ... See full document
16
A Long Term Study of Efficacy of Patients with Macular Edema Secondary to BRVO Treated with Ranibizumab Combined with Compound Salvia
... Branch retinal vein occlusion is the second most common cause of retinal vascular blindness after diabetic reti- nopathy ...and macular edema. Macular edema ... See full document
136
A clinical study on management of retinal vascular occlusive disorders.
... with macular edema secondary to BRVO, and concluded that there was no difference identified in VA at 12 months for the standard care group compared with the triamcinolone groups; however, rates of adverse ... See full document
72
The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
... significant retinal thinning compared to IVB in ischemic BRVO in the first 3 ...like ranibizumab or combination of IVTA and IVB should also be considered in the treatment of BRVO-related ... See full document
21
Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion
... underwent grid photocoagulation combined with IVB for macular edema associated with RVO that recurred after the previous ...showed macular edema with a loss of ...recurrent ... See full document
6
Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
... intravitreal bevacizumab, such as endophthalmitis, cataract, glaucoma, retinal detachment, or thromboembolic events, except for one case of uveitis that was completely resolved with topi- cal steroids and ... See full document
18
Intravitreal Bevacizumab with Grid Photocoagulation for Recurrent Macular Edema Secondary to Retinal Vein Occlusion
... Intravitreal injections were performed under complete sterile conditions using bovidine iodine 10% for eye lid skin and 5% for ocular surface wash. After complete draping, surface anesthesia was applied. Intravitreal in- ... See full document
12
Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion
... Patients were examined at baseline (day 0), week 1, and then monthly from months 1 to 12. At each visit, patients underwent a complete ocular examination. The BCVA was expressed as decimal VA using a Landolt C chart and ... See full document
5
Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion
... the ranibizumab treatment period and the aflibercept treatment ...Mean retinal thickness of the area corresponding to the central retinal subfield in the Early Treatment of Diabetic Retinopathy Study ... See full document
12
A Study on the Effectiveness of Early Sectoral Photocoagulation in Branch Retinal Vein Occlusion at a Tertiary Care Center
... of macular edema in BRVO ...receive macular grid laser , 1mg IVTA , 4 mg IVTA ...of macular edema measured by OCT at the end of 12 months between each group ...for ... See full document
111
A review of optical coherence tomography angiography (OCTA)
... for retinal vascular ...to retinal vascular ...artifact due to patient movement/ ...related macular degeneration (AMD), diabetic retinopathy, artery and vein occlusions, and ...the ... See full document
11
Intravitreal bevacizumab injections for diabetic macular edema – predictors of response: a retrospective study
... Results: Twenty-eight percent of patients had an anatomical response after the first course of IVB. Systemic hypertension (odds ratio, 95% confidence interval: 12.1, 0.7–21) was a statisti- cally significant predictor ... See full document
14
<p>Vitrectomy for macular edema due to retinal vein occlusion</p>
... macular edema. In the pre-treated patients with recurrent or persistent macular edema, we recom- mended vitrectomy, as have many other ... See full document
7
Correlation between short- and long-term effects of intravitreal ranibizumab therapy on macular edema after branch retinal vein occlusion: a prospective observational study
... the macular edema associated with ...intravitreal bevacizumab (IVB) (Avastin, Genentech ...for macular edema sec- ondary to BRVO achieved similar visual outcomes with fewer injections ... See full document
16
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
... after 2 years; the follow-up period of the dexamethasone study is still not long enough to compare cataract progres- sion ...enhanced due to shorter follow-up times in the dexamethasone and triamcinolone ... See full document
36
Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab
... Even though an optimal treatment regimen is as yet unclear, our data suggests that treatment should be initi- ated even if BRVO has been present for a while: in our patients the temporal delay from diagnosis to treatment ... See full document
9
Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review
... for ranibizumab with the other treatments for ...of ranibizumab, ROCC, this smaller study did not report the proportion of patients gaining at least 15 letters, the outcome measure common to all the ... See full document
6
Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
... ME due to ...had macular edema secondary to BRVO treated with ...after occlusion. The initial therapy was three intravitreal bevacizumab injections at monthly intervals with ...central ... See full document
30
Related subjects